Craig E. Coleman - May 27, 2024 Form 4 Insider Report for UNIVERSAL BIOSENSORS INC (UBI)

Signature
/s/ David St. Quintin, as attorney-in-fact
Stock symbol
UBI
Transactions as of
May 27, 2024
Transactions value $
$156,342
Form type
4
Date filed
5/28/2024, 08:47 AM
Previous filing
May 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBI Common Stock Purchase $156K +1.42M +1.65% $0.11* 87.5M May 27, 2024 By Partnership F1, F2, F3, F4
holding UBI Common Stock 971K May 27, 2024 By the Coleman Super Fund F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding UBI Stock Option (Right to Buy) 43.1M May 27, 2024 Common Stock 43.1M $0.20 By Partnership F3, F6
holding UBI Stock Option (Right to Buy) 217K May 27, 2024 Common Stock 217K $0.20 By the Coleman Super Fund F5
holding UBI Stock Option (Right to Buy) 1.92M May 27, 2024 Common Stock 1.92M $0.92 By Partnership F3, F7
holding UBI Stock Option (Right to Buy) 1.92M May 27, 2024 Common Stock 1.92M $1.00 By Partnership F3, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Traded as Chess Depository Interests ("CDIs") on the Australian Stock Exchange. CDIs represent beneficial interests in the common stock held by CHESS Depository Nominees Pty Ltd.
F2 The price reported is stated in Australian dollars.
F3 The Reporting Person is a director of Viburnum, which is the manager of each of VF Strategic Equities Fund ("Strategic Fund") and separately managed accounts on behalf of a Viburnum client ("Strategic Mandates") the direct beneficial owners of the common stock and stock options. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the common stock and stock options held by Strategic Fund, and Strategic Mandates, except to the extent of his pecuniary interest therein.
F4 Viburnum, as the manager of Strategic Fund and Strategic Mandates, may be deemed to beneficially own 87,509,318 shares of common stock, which consists of 38,876,431 and 48,632,887 shares of common stock held by Strategic Fund and Strategic Mandates, respectively. Viburnum, as the manager of each of Strategic Fund and Strategic Mandates, shares voting and dispositive power over, and may be deemed to beneficially own, the common stock held by the foregoing entities. The Reporting Person shares voting and dispositive power over, and may be deemed to beneficially own, the common stock held by the foregoing entities due to the Reporting Person serving as a director of Viburnum.
F5 The Reporting Person and Phylis Coleman are the trustees of the Coleman Super Fund, of which the Reporting Person is a potential beneficiary.
F6 Viburnum, as the manager of Strategic Fund and Strategic Mandates, may be deemed to beneficially own 43,138,991 stock options which an exercise price of A$0.20 and expiry date of 05/08/2027.
F7 Viburnum, as the manager of Strategic Fund and Strategic Mandates, may be deemed to beneficially own 1,920,000 stock options which an exercise price of A$0.92 and expiry date of 05/26/2025.
F8 Viburnum, as the manager of Strategic Fund and Strategic Mandates, may be deemed to beneficially own 1,920,000 stock options which an exercise price of A$1.00 and expiry date of 05/26/2025.